Radiation with concurrent late chemotherapy intensification ('chemoboost') for locally advanced head and neck cancer

Radiotherapy and Oncology

Volumn 54, Issue 2, 2000, Pages 123-127

  Corry, June ^a   Rischin, Danny ^a   Smith, Jennifer G ^a   D'Costa, Ieta A ^a   Huges, Peter G ^a   Sexton, Maree A ^a   Sizeland, Andrew ^b   Lyons, Bernard ^c   Peters, Lester J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

Chemotherapy; Head and neck cancer; Radiotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; METASTASIS; MOUTH ULCER; MUCOSA INFLAMMATION; MULTICENTER STUDY; NAUSEA; NEUTROPENIA; PNEUMONIA; PRIORITY JOURNAL; RADIOTHERAPY; RECURRENCE RISK; SEPTICEMIA; SKIN MANIFESTATION; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; VOMITING; XEROSTOMIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033996425     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(99)00182-6     Document Type: Article

References (27)

1. Amdur R.J., Parsons J.T., Mendenhall W.M., Million R.R., Stringer S.P., Cassisi N.J. Postoperative irradiation for squamous cell carcinoma of the head and neck: an analysis of treatment results and complications. Int. J. Radiat. Oncol. Biol. Phys. 16:1989;25-36.
2. Ang K.K., Peters L.J., Weber R.S., et al. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int. J. Radiat. Oncol. Biol. Phys. 19:1990;1339-1345.
3. Bourhis J., Eschwege F. Radiotherapy-chemotherapy combinations in head and neck squamous cell carcinoma: overview of randomized trials. Anticancer Res. 16:1996;2397-2402.
4. Brizel D.M., Albers M.E., Fisher S.R., et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N. Engl. J. Med. 338:1998;1798-1804.
5. Dische S., Saunders M., Barrett A., Harvey A., Gibson D., Parmar M. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother. Oncol. 44:1997;123-136.
6. Dubois J.B., Guerrier B., Di Ruggiero J.M., Pourquier H. Cancer of the piriform sinus: treatment by radiation therapy alone and with surgery. Radiology. 160:1986;831-836.
7. Garden A.S., Glisson B.S., Ang K.K., et al. Phase I/II trial of radiation with chemotherapy 'boost' for advanced squamous cell carcinomas of the head and neck: toxicities and responses. J. Clin. Oncol. 17:1999;2390-2395.
8. Hermanek P., Sobin L.H. TNM classification of malignant tumours, 4th ed., 2nd revision. 1992;Springer-Verlag, Berlin.
9. Horiot J.C., Bontemps P., van den Bogaert W., et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother. Oncol. 44:1997;111-121.
10. Horiot J.C., Le Fur R., N'Guyen T., et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother. Oncol. 25:1992;231-241.
11. Jackson S.M., Weir L.M., Hay J.H., Tsang V.H.Y., Durham J.S. A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiother. Oncol. 43:1997;39-46.
12. Jacobs C., Lyman G., Velez-Garcia E., et al. A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J. Clin. Oncol. 10:1992;257-263.
13. Jeremic B., Shibamoto Y., Stanisavljevic B., Milojevic L., Milicic B., Nikolic N. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. Radiother. Oncol. 43:1997;29-37.
14. Kalbfleisch J.D., Prentice R.L. The statistical analysis of failure time data. 1980;Wiley, New York.
15. Kramer S., Gelber R.D., Snow J.B., et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg. 10:1987;19-30.
16. Lefebvre J.L., Chevalier D., Luboinski B., Kirkpatrick A., Collette L., Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J. Natl. Cancer Inst. 88:1996;890-899.
17. Mehta C., Patel N. StatXact 4 for Windows, version 4.0.1. 1999;Cytel Software Corporation, Cambridge, MA.
18. Munro A.J. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br. J. Cancer. 71:1995;83-91.
19. Perez C.A., Brady L.W. Principles and practice of radiation oncology, 2nd ed. 1992;51-53 Lippincott, Philadelphia, PA.
20. Peters L.J., Goepfert H., Ang K.K., et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 26:1993;3-11.
21. Peters L.J., Withers H.R. Applying radiobiological principles to combined modality treatment of head and neck cancer-the time factor. Int. J. Radiol. Biol. Phys. 39:1997;831-836.
22. Sanchíz F., Millá A., Torner J., et al. Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys. 19:1990;1347-1350.
23. S-plus, version 4.5.1. 1998;Data Analysis Products Division, MathSoft, Seattle, WA.
24. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N. Engl. J. Med. 1991;324:1685-1690.
25. Vikram B., Strong E.W., Shah J., Spiro R.H. Elective postoperative radiation therapy in stages III and IV epidermoid carcinoma of the head and neck. Am. J. Surg. 140:1980;580-584.
26. Vikram B., Strong E.W., Shah J.P., Spiro R. Failure at the primary site following multimodality treatment in advanced head and neck cancer. Head Neck Surg. 6:1984;720-723.
27. Vikram B., Strong E.W., Shah J.P., Spiro R. Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head Neck Surg. 6:1984;730-733.